期刊文献+

脓毒症及其免疫调理治疗

暂未订购
导出
摘要 脓毒症(sepsis)是严重创伤、烧伤、休克、大手术和感染后的常见并发症。美国每年约有75万脓毒症患者,我国每年约有300万例患者发生脓毒症。随着微生物耐药、老年人口的增长以及人们对脓毒症的认识水平的提高,脓毒症发病率还有增加的趋势。现代医学的进步挽救了很多危重病患者的生命。
出处 《临床外科杂志》 2011年第3期157-159,共3页 Journal of Clinical Surgery
  • 相关文献

参考文献18

  • 1Schmidt H,Hennen R,Keller A,et al. Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome [ J]. Intensive Care Med ,2006,32 (8) : 1248-1251.
  • 2Nguyen LN, Nguyen TG. Characteristics and outcomes of multiple organ dysfunction syndrome among severe burn patients [ J ]. Burns, 2009, 35(7) :937-941.
  • 3Bone RC. Sir Isaac Newton, Sepsis, SIRS, and CARS [ J ]. Crit Care Med,1996,24(7) :1125-1128.
  • 4Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock [ J ]. Crit Care Med, 2002,30 (6) : 1250-1255.
  • 5Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cy tokine response in pneumonia and sepsis:results of the Genetic and In flammatory Markers of Sepsis (GenlMS) Study [ J ]. Arch Intern Med, 2007,167 ( 15 ) : 1655-1663.
  • 6林洪远,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2):67-69. 被引量:85
  • 7Hotchkiss RS,Karl IE. The pathophysiology and treatment of sepsis[J]. New Engl J Med,2003,348(2) :138-150.
  • 8Song M, Kellum JA. Interleukin 6 [ J ]. Crit Care Med, 2005,33 ( 12 Suppl ) : S463-465.
  • 9Frost RA,Lang CH. Skeletal muscle cytokines:regulation by pathogen associated molecules and catabolic hormones [ J ]. Curr Opin Clin Nutr Metab Care ,2005,8 ( 3 ) :255-263.
  • 10Kox WJ, Volk T, Kox SN, et al. Immunomodulatory therapies in sepsis [ J]. Intensive Care Med ,2000,26( Suppl 1 ) :S124-128.

二级参考文献61

  • 1冯国辉,雷志礼,宇鹏,宁新宇,韦中余,李军,刘多辉,董兰,韩暑君,李会光.乌司他丁对原位肝移植术患者围术期肾功能的影响[J].中华麻醉学杂志,2005,25(11):853-855. 被引量:3
  • 2蔡国龙,严静,虞意华,张昭才,龚仕金,戴海文,陈建国.高容量血液滤过对老年感染性休克合并MODS患者细胞因子的影响[J].中华急诊医学杂志,2006,15(1):57-60. 被引量:19
  • 3姚宁,方国恩,杜成辉,赵为国,王冰.早期高容量血液滤过对多器官功能障碍综合征及中性粒细胞功能的影响[J].中华急诊医学杂志,2006,15(11):990-993. 被引量:11
  • 4Bellomo R,Tipping P,Boyce N.Continuous venovenous hemofiltration with dialysis removes cytokines fromthe circulation of septic patients[J].Crit Care Med,1993,21(4):522.
  • 5Brain R,McDonald BR,Metha RL.Decreasod mortality in patients with acute renal failure undergoing continuous arteiovenons hemodialysis[J].Contrib Nephrol,1991,93(1):51.
  • 6Heering R,Morgera S,Schmitz G,ct al.Cytokines removal and cardiovascular hemodynamies in septic patients with continuous hemofiltration[J].Intensive Care Med,1997,23(3):288.
  • 7Kouche K,Cavadore P,Portales P,et al.Continuous venovenous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF2-α and IL-6 plasma concentrations[J].J Nephrol,2002,15(2):150.
  • 8Sander A,Armbruster W,Sander B,et al.Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF-α plasma concentrations[J].Intensive Care Med,1997,23(10):878.
  • 9Bone R.Immunologic dissonance:A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the ronhiple organ dysfunction syndrome[J].Ann Int Med,1996,125 (8):680-687.
  • 10Aderem A,Ulevitch RJ.Toll-like receptors in the induction of the innate immune response[J].Nature,2000,406(6797):782-787.

共引文献187

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部